Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Subtype-specific regulatory network rewiring in acute myeloid leukemia [Hi-C]

ABSTRACT: Subtype-specific regulatory network rewiring in acute myeloid leukemia [Hi-C]

PROVIDER: PRJNA423089 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6392077_1.fastq.gz	Fastqsanger.gz
	SRR6392077_2.fastq.gz	Fastqsanger.gz
	SRR6392078_1.fastq.gz	Fastqsanger.gz
	SRR6392078_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Subtype-specific regulatory network rewiring in acute myeloid leukemia

Project description:Subtype-specific regulatory network rewiring in acute myeloid leukemia

| PRJNA423094 | ENA

Subtype-specific regulatory network rewiring in acute myeloid leukemia [RNA-seq]

Project description:Subtype-specific regulatory network rewiring in acute myeloid leukemia [RNA-seq]

| PRJNA423049 | ENA

Subtype-specific regulatory network rewiring in acute myeloid leukemia [DNase-Hypersensitivity]

Project description:Subtype-specific regulatory network rewiring in acute myeloid leukemia [DNase-Hypersensitivity]

| PRJNA423045 | ENA

Subtype-specific regulatory network rewiring in acute myeloid leukemia [Hi-C]

Project description:Acute myeloid leukemia is a heterogeneous disease which is subdivided into different categories defined by disease-causing mutations in transcription factors, epigenetic regulators and signalling molecules. How different mutant regulators establish AML-specific transcriptional networks is unclear. Here we performed a comprehensive analysis of mutation-specific sets of cis-regulatory elements driving gene expression in AML blast cells from a carefully selected group of patients with alterations in genes encoding transcription factors (RUNX1, CEBPA) and signalling molecules (FTL3-ITD, RAS, NPM1). We show that each mutant regulator establishes a specific transcriptional and signalling network unrelated to normal cells driving the expression of unique sets of genes required for AML survival.

2018-09-20 | GSE108303 | GEO

Subtype-specific regulatory network rewiring in acute myeloid leukemia [DNase-Hypersensitivity]

2018-09-20 | GSE108246 | GEO

Subtype-specific regulatory network rewiring in acute myeloid leukemia [RNA-seq]

2018-09-20 | GSE108266 | GEO

Subtype-specific regulatory network rewiring in acute myeloid leukemia.

Project description:Acute myeloid leukemia (AML) is a heterogeneous disease caused by a variety of alterations in transcription factors, epigenetic regulators and signaling molecules. To determine how different mutant regulators establish AML subtype-specific transcriptional networks, we performed a comprehensive global analysis of cis-regulatory element activity and interaction, transcription factor occupancy and gene expression patterns in purified leukemic blast cells. Here, we focused on specific subgroups of subjects carrying mutations in genes encoding transcription factors (RUNX1, CEBPα), signaling molecules (FTL3-ITD, RAS) and the nuclear protein NPM1). Integrated analysis of these data demonstrates that each mutant regulator establishes a specific transcriptional and signaling network unrelated to that seen in normal cells, sustaining the expression of unique sets of genes required for AML growth and maintenance.

| S-EPMC6330064 | biostudies-literature

Subtype-Specific and Structure Variation-Induced Chromatin Spatial Reorganization in Acute Myeloid Leukemia [Hi-C]

Project description:Subtype-Specific and Structure Variation-Induced Chromatin Spatial Reorganization in Acute Myeloid Leukemia [Hi-C]

| PRJNA638402 | ENA

Subtype-Specific and Structure Variation-Induced Chromatin Spatial Reorganization in Acute Myeloid Leukemia [Hi-C]

Project description:Acute myeloid leukemia (AML) is a set of heterogeneous myeloid malignancies hallmarked by mutations in epigenetic modifiers, transcription factors and kinases that can cause epigenetic reshaping. It is unclear whether those mutations drive chromatin 3D structure alteration and contribute to oncogenic dysregulation in AML. By performing Hi-C and whole genome sequencing in 21 primary AML and healthy donors’ samples, we identified recurrent AML- or subtype-specific alteration of compartments, TADs, and chromatin loops. To study the impact on gene regulation, we performed RNA-Seq, ATAC-Seq and CUT&TAG for CTCF, H3K27ac, and H3K27me3 in the same samples. We observed dysregulation of many AML-related genes, represented by MYCN, MEIS1, WT1, ERG, MYC GATA3, BCL11B and IKZF2, intimately linked to the recurrent gain of loops and switch of compartment or TAD, alongside acquisition of AML-specific enhancer or repressor. Further, we profiled structure variations using WGS and Hi-C data to reconstruct the cancer 3D genome, by which we identified structure variation-induced neo-loops and enhancer-hijacking events. Furthermore, through conducting whole genome bisulfite sequencing in patient samples, we found altered methylation correlated with A/B compartment switch, and loss of CTCF insulation due to hypermethylation, leading to extensive gain of loops in AML. By treating the AML cells with DNA hypomethylation agent 5-azacytidine, the altered chromatin structure and gene expression can be restored, with switched compartment reverted and gained loops dissociated, alongside compromised AML cell proliferation, overall providing insights into AML treatment through therapeutic restoration of chromatin structure.

2022-07-19 | GSE152135 | GEO

Subtype-specific regulatory network rewiring in acute myeloid leukemia

Project description:This SuperSeries is composed of the SubSeries listed below.

2018-09-20 | GSE108316 | GEO